Multiple sclerosis. Chlamydia hypothesis put to the test;Multiple sklerose. Chlamydien-hypothese in der diskussion

Nervenarzt

Volumn 72, Issue 10, 2001, Pages 820-823

  Derfuss T ^a,b   Hohlfeld, R ^a,b   Meinl, E ^a,b  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chlamydia pneumoniae; Intrathecal immunoglobulin production; Multiple sclerosis; Oligoclonal bands

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; BORRELIA INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION;

ANTIGENS, BACTERIAL; BORRELIA; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULINS; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS;

EID: 0034797063     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150170041     Document Type: Article

References (31)

1. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS
2. Quantitation of intrathecal measles Virus IgG antibody synthesis rate: Subacute sclerosing panencephalitis and multiple sclerosis
3. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response
4. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis
5. Chlamydia: A role for multiple sclerosis or more confusion?
6. Guillain-Barre syndrome after Chlamydia pneumoniae infection
7. Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?
8. Chlamydia pneumoniae strain TWAR pharyngitis in US Air Force basic trainees
9. Sporadic bovine encephalomyelitis
10. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives
11. Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis
12. Neurological complications of chlamydial infections: Case report and review
13. Chlamydia pneumoniae associated with central nervous system infections
14. Chlamydia pneumoniae-specific humoral immune responses and clinical disease parameters in multiple sclerosis
15. Multiple sclerosis in time and space -geographic clues to cause
16. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis
17. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
18. Affinity distributions of antigen-specific IgG in patients with multiple sclerosis and in patients with viral encephalitis
19. Affinity of antigen-specific IgG distinguishes multiple sclerosis from encephalitis
20. Concepts of viral pathogenesis of multiple sclerosis
21. Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients?
22. Lack of Chlamydia infection of the central nervous system in multiple sclerosis
23. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: Sensitive and specific detection of antibody synthesis in brain
24. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis
25. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis
26. Chlamydia pneumonia and meningoencephalitis
27. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS
28. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
29. Multiple sclerosis and Chlamydia pneumoniae
30. Chlamydia infections in neurology
31. CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens